复发性甲状腺癌的射频消融:2025年韩国甲状腺放射学会指南
韩国甲状腺放射学会基于对现有文献的综合分析和专家共识,更新了复发性甲状腺癌射频消融治疗指南;射频消融是良性甲状腺结节、复发性甲状腺癌和原发性甲状腺微小癌患者手术的微创替代方案。
要点
- 射频消融可作为复发性甲状腺癌患者手术的微创替代治疗方案。
- 本指南由韩国甲状腺放射学会基于文献综合分析与专家共识制定更新。
- 指南适用于复发性甲状腺癌的射频消融管理。
核心结论
- 韩国甲状腺放射学会基于文献综合分析和专家共识更新了复发性甲状腺癌射频消融治疗指南。
研究设计与样本
- 韩国甲状腺放射学会工作组委员会基于对现有文献的综合分析和专家共识制定指南;该学会曾于2009年制定甲状腺肿瘤射频消融推荐,并于2012年和2017年修订。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Radiofrequency ablation (RFA) is a minimally invasive treatment modality used as an alternative to surgery in patients with benign thyroid nodules, recurrent thyroid cancers (RTCs), and primary thyroid microcarcinomas. The Korean Society of Thyroid Radiology (KSThR) initially developed recommendations for the optimal use of RFA for thyroid tumors in 2009 and revised them in 2012 and 2017. As new meaningful evidence has accumulated since 2017 and in response to a growing global interest in the use of RFA for treating malignant thyroid lesions, the task force committee members of the KSThR decided to update the guidelines on the use of RFA for the management of RTCs based on a comprehensive analysis of current literature and expert consensus.
引用
- Ha EJ, Lee MK, Baek JH, et al. Radiofrequency Ablation for Recurrent Thyroid Cancers: 2025 Korean Society of Thyroid Radiology Guideline. Korean J Radiol. 2025. PMID: 39780628. doi:10.3348/kjr.2024.0963
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。